<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04172285</url>
  </required_header>
  <id_info>
    <org_study_id>EXERSARCO</org_study_id>
    <nct_id>NCT04172285</nct_id>
  </id_info>
  <brief_title>Physical Activity Program for Counteracting Sarcopenia</brief_title>
  <acronym>EXERSARCO</acronym>
  <official_title>Effects of an Home-base Physical Activity Program for Counteracting Sarcopenia in Elderly: a Randomized-controlled Trial.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Istituto Ortopedico Galeazzi</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Istituto Ortopedico Galeazzi</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      Sarcopenia is a pathophysiological process associated with aging and some metabolic
      conditions characterized by progressive muscle tissue loss, which may lead to loss of
      strangth and performance and increase risk of falls and fractures, physical disability and
      premature death. Therefore, it is necessary to identify personalized programs of physical
      activity and supplementation for elderly population in order to improve their physical
      functions, muscle strengh and body composition.

      With the present project we aime to assess the effect of a feasible home-based exercise
      program coupled with food supplementation to improve muscle strength, muscle volume and
      muscle physical performance potentially associated with sarcopenia in elderly people.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">September 18, 2019</start_date>
  <completion_date type="Anticipated">December 20, 2020</completion_date>
  <primary_completion_date type="Anticipated">December 20, 2020</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Participant)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Lower limb strength</measure>
    <time_frame>Week 12</time_frame>
    <description>Assessed by chair stand test</description>
  </primary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Anticipated">36</enrollment>
  <condition>Sarcopenia</condition>
  <arm_group>
    <arm_group_label>Physical activity group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Physical activity and supplementation group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Control group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Physical activity</intervention_name>
    <description>Home-based physical activity program</description>
    <arm_group_label>Physical activity group</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Physical activity and supplementation</intervention_name>
    <description>Home-based physical activity program and amminoacid supplementation</description>
    <arm_group_label>Physical activity and supplementation group</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Control</intervention_name>
    <description>No intervention</description>
    <arm_group_label>Control group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Sedentary lifestyle.

          -  Cognitively intact.

          -  Autonomous walking.

          -  Acceptance of informed consent.

        Exclusion Criteria:

          -  Body mass index lower than 18.5 and uppen than 40 kg/m2.

          -  History of cancer.

          -  Pacemaker user.

          -  History of epileptic episodes.

          -  Endocrine-metabolic, neurological, muscular and ortopedic pathologies that affect
             movement functions.

          -  Bone fractures that influence movement functions.

          -  Smoking.

          -  Surgical treatments in the prior 6 months.

          -  Use of antieptilectics, glucocorticoids, rhGH and testosterone.

          -  Hepatic and muscular pathologies
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>60 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Matteo Bonato, Ph.D.</last_name>
    <phone>00390266214980</phone>
    <email>matteo.bonato@grupposandonato.it</email>
  </overall_contact>
  <location>
    <facility>
      <name>IRCCS Istituto Ortopedico Galeazzi</name>
      <address>
        <city>Milan</city>
        <zip>20141</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Elena Cittera</last_name>
      <phone>00390266214057</phone>
      <email>elena.cittera@grupposandonato.it</email>
    </contact>
  </location>
  <location_countries>
    <country>Italy</country>
  </location_countries>
  <verification_date>November 2019</verification_date>
  <study_first_submitted>November 13, 2019</study_first_submitted>
  <study_first_submitted_qc>November 20, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">November 21, 2019</study_first_posted>
  <last_update_submitted>November 20, 2019</last_update_submitted>
  <last_update_submitted_qc>November 20, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">November 21, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Sarcopenia</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

